Kamada Ltd. (KMDA)
8.43
+0.19
(+2.31%)
USD |
NASDAQ |
Aug 24, 16:00
8.42
-0.01
(-0.12%)
After-Hours: 20:00
Kamada Net Income (Quarterly) : 9.262M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.262M |
| March 31, 2026 | 4.132M |
| December 31, 2025 | 3.562M |
| September 30, 2025 | 5.296M |
| June 30, 2025 | 7.376M |
| March 31, 2025 | 3.964M |
| December 31, 2024 | 3.808M |
| September 30, 2024 | 3.863M |
| June 30, 2024 | 4.426M |
| March 31, 2024 | 2.365M |
| December 31, 2023 | 5.058M |
| September 30, 2023 | 3.223M |
| June 30, 2023 | 1.812M |
| March 31, 2023 | -1.809M |
| December 31, 2022 | 2.944M |
| September 30, 2022 | 0.484M |
| June 30, 2022 | -3.921M |
| March 31, 2022 | -1.828M |
| December 31, 2021 | -5.009M |
| September 30, 2021 | -0.845M |
| June 30, 2021 | 0.937M |
| March 31, 2021 | 2.687M |
| December 31, 2020 | 1.629M |
| September 30, 2020 | 6.835M |
| June 30, 2020 | 3.458M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.218M |
| December 31, 2019 | 5.362M |
| September 30, 2019 | 5.823M |
| March 31, 2019 | 4.923M |
| December 31, 2018 | 17.74M |
| September 30, 2018 | -2.391M |
| June 30, 2018 | 5.686M |
| March 31, 2018 | 1.256M |
| December 31, 2017 | 6.252M |
| September 30, 2017 | -0.236M |
| June 30, 2017 | 4.862M |
| March 31, 2017 | -3.977M |
| December 31, 2016 | -1.808M |
| September 30, 2016 | -1.041M |
| June 30, 2016 | -1.585M |
| March 31, 2016 | -2.299M |
| December 31, 2015 | 0.988M |
| September 30, 2015 | -4.622M |
| June 30, 2015 | -2.342M |
| March 31, 2015 | -5.294M |
| December 31, 2014 | 1.745M |
| September 30, 2014 | -2.897M |
| June 30, 2014 | -8.362M |
| March 31, 2014 | -3.122M |
| December 31, 2013 | 1.551M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| BioLineRx Ltd. | -2.581M |
| XTL Biopharmaceuticals Ltd. | -- |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | -1.91M |
| Revium Recovery, Inc. | -0.584M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 54.92M |
| Total Expenses (Quarterly) | 45.66M |
| EPS Diluted (Quarterly) | 0.1605 |
| Enterprise Value | 428.03M |
| Gross Profit Margin (Quarterly) | 40.91% |
| Profit Margin (Quarterly) | 16.86% |
| Earnings Yield | 4.53% |
| Operating Earnings Yield | 5.62% |
| Normalized Earnings Yield | 4.645 |